Tekla Life Sciences Investors

Financial Services

NYSE:HQL · New York Stock Exchange

Market Cap $509.79M Beta 0.74 P/E (TTM) 2.6

$16.95 +0.53%

+$0.09 today

52W Low $12.34High $18.46

Vol 0.10M · Avg 0.10M

EPS (TTM)$6.52

Div Yield12.04%

Asset Management

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+49.47%

Period High

$17.86

Period Low

$11.01

Latest

$16.95

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Gladstone Investment Corporation

NASDAQ:GAIN

$613.21M

Eagle Point Credit Company Inc.

NYSE:ECC

$505.04M

Gladstone Capital Corporation

NASDAQ:GLAD

$438.08M

Crescent Capital BDC, Inc.

NASDAQ:CCAP

$414.89M

Source Capital, Inc.

NYSE:SOR

$372.45M

Barings Corporate Investors

NYSE:MCI

$365.89M

CION Investment Corporation

NYSE:CION

$347.53M

BlackRock TCP Capital Corp.

NASDAQ:TCPC

$317.99M

PennantPark Investment Corporation

NYSE:PNNT

$251.39M

GigCapital7 Corp.

GIG

$172.00M

What is the latest HQL filing?

The latest filing shown is 3 dated Jun 11, 2026.

How many recent filings does HQL have?

Intrinsic Alpha currently shows 20 recent filings for HQL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.